Back
Spero Therapeutics Quote, Financials, Valuation and Earnings
Sell
43
SPRO
Spero Therapeutics
Last Price:
1.59
Seasonality Move:
-16.99%
7 Day Trial
ALL ACCESS PASS
$
7
Spero Therapeutics Price Quote
$1.59
Spero Therapeutics Key Stats
Sell
43
Spero Therapeutics (SPRO)
is a Sell
Day range:
$1.53 - $1.61
52-week range:
$0.99 - $1.94
Dividend yield:
0%
P/E ratio:
3.70
P/S ratio:
0.84
P/B ratio:
0.89%
Volume:
178.3K
Avg. volume:
177.2K
1-year change:
-12.64%
Market cap:
$85.8M
Revenue:
$96.7M
EPS:
$0.44
How Much Does Spero Therapeutics Make?
-
How Much Are Spero Therapeutics's Sales Annually?
SPRO Revenues are $96.7M -
How Much Profit Does Spero Therapeutics's Make A Year?
SPRO net income is $22.8M
Is Spero Therapeutics Growing As A Company?
-
What Is Spero Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 4.68% -
What Is Spero Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Spero Therapeutics Stock Price Performance
-
Did Spero Therapeutics Stock Go Up Last Month?
Spero Therapeutics share price went up by 6% last month -
Did SPRO's Share Price Rise Over The Last Year?
SPRO share price fell by -12.64% over the past 1 year
What Is Spero Therapeutics 52-Week High & Low?
-
What Is Spero Therapeutics’s 52-Week High Share Price?
Spero Therapeutics has traded as high as $1.94 over the past 52 weeks -
What Is Spero Therapeutics’s 52-Week Low Share Price?
Spero Therapeutics has traded as low as $0.99 over the past 52 weeks
Spero Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Spero Therapeutics?
-
How Much Debt Does Spero Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Spero Therapeutics Have?
Cash and short term investments quarterly total is $82.3M -
What Is Spero Therapeutics’s Book Value Per Share?
Book value per share is 1.79
Is Spero Therapeutics Cash Flow Positive?
-
What Is SPRO Cash Flow From Operations?
Cash flow from operations (TTM) is -$14.2M -
What Is Spero Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $0 -
What Is Spero Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $0
Spero Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
SPRO return on invested capital is 31.08% -
What Is Spero Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is 17.5% -
What Is SPRO Return On Equity?
ROE is a measure of profitability and is 31.08%
Spero Therapeutics Earnings Date & Stock Price
-
What Is Spero Therapeutics's Stock Price Today?
A single share of SPRO can be purchased today for 1.59 -
What Is Spero Therapeutics’s Stock Symbol?
Spero Therapeutics trades on the nasdaq under the ticker symbol: SPRO -
When Is Spero Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Spero Therapeutics is scheduled on August 9, 2024 -
When Is SPRO's next ex-dividend date?
Spero Therapeutics's next ex-dividend date is September 16, 2015 -
How To Buy Spero Therapeutics Stock?
You can buy Spero Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Spero Therapeutics Competitors
-
Who Are Spero Therapeutics's Competitors?
Below is a list of companies who compete with Spero Therapeutics or are related in some way:
Spero Therapeutics Dividend Yield
Data Unavailable
Spero Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -269.23% |
| Revenue: | 468.11% | -56.96% |
Analyst Recommendations
| Buy Recommendations: | 2 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 7.50 |
| Upside from Last Price: | 371.7% |